The challenge of indication extrapolation for infliximab biosimilars.
Feagan BG, Choquette D, Ghosh S, Gladman DD, Ho V, Meibohm B, Zou G, Xu Z, Shankar G, Sealey DC, Russell AS.
Feagan BG, et al. Among authors: sealey dc.
Biologicals. 2014 Jul;42(4):177-83. doi: 10.1016/j.biologicals.2014.05.005. Epub 2014 Jun 21.
Biologicals. 2014.
PMID: 24962198
Free article.
Review.